APOE Genotype-specific Methylation Patterns are Linked to Alzheimer Disease Pathology and Estrogen Response

Rebecca Panitch,Nathan Sahelijo,Junming Hu,Kwangsik Nho,Rhoda Au,David A Bennett,Kathryn L Lunetta,Thor D Stein,Lindsay A Farrer,Gyungah R Jun,The Alzheimer's Disease Neuroimaging Initiative

DOI: https://doi.org/10.1101/2022.12.20.22283744

2022-12-23

MedRxiv

Abstract:The joint effects of APOE genotype and DNA methylation on Alzheimer disease (AD) risk is relatively unknown. We conducted genome-wide methylation analyses using 2,021 samples in blood (91 AD cases, 329 mild cognitive impairment, 1,391 controls) and 697 samples in brain (417 AD cases, 280 controls). We identified differentially methylated levels in AD compared to controls in an APOE genotype-specific manner at 25 cytosine-phosphate-guanine (CpG) sites in brain and 36 CpG sites in blood. Additionally, we identified seven CpG sites in the APOE region containing TOMM40, APOE, and APOC1 genes with P<5x10-8 between APOE {varepsilon}4 carriers and non-carriers in brain or blood. In brain, the most significant CpG site hypomethylated in {varepsilon}4 carriers compared to non-carriers) was from the TOMM40 in the total sample, while most of the evidence was derived from AD cases. However, the CpG site was not significantly modulating expression of these three genes in brain. Three CpG sites from the APOE were hypermethylated in APOE {varepsilon}4 carriers in brain or blood compared in {varepsilon}4 non-carriers and nominally significant with APOE expression in brain. Three CpG sites from the APOC1 were hypermethylated in blood, which one of the 3 CpG sites significantly lowered APOC1 expression in blood using all subjects or {varepsilon}4 non-carriers. Co-methylation network analysis in blood and brain detected eight methylation networks associated with AD and APOE {varepsilon}4 status. Five of the eight networks included genes containing network CpGs that were significantly enriched for estradiol perturbation, where four of the five networks were enriched for the estrogen response pathway. Our findings provide further evidence of the role of APOE genotype on methylation levels associated with AD, especially linked to estrogen response pathway.